The results showed that whilst the positive rate of IGF2BP2 in ESCC tissue reached 96.9% (95/98) (Figure 1D), the IGF2BP2 expression was not correlated with clinicopathological parameters, such as age, gender, tumor-node-metastasis (TNM) stage and differentiation (Table 1). Here, IGF2BP2 is linked to esophageal squamous cell carcinoma.